Log in to search using one of your social media accounts:

 

Sabga Foundation pledges $1M toward TGen pancreatic cancer research
(Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 17, 2017 Category: American Health Authors: Angela Gonzales Source Type: news

It ’s Time To Demand Better For Those Fighting The World’s Toughest Cancer
Let’s turn World Pancreatic Cancer Day from a day of awareness into a day of action. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 16, 2017 Category: Consumer Health News Source Type: news

Yankees star on the devastating toll of pancreatic cancer
David Robertson lost his father-in-law to pancreatic cancer. Now, he's hoping to raise awareness about the deadly disease (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 16, 2017 Category: Consumer Health News Source Type: news

Yankees pitcher on the devastating toll of pancreatic cancer
David Robertson lost his father-in-law to pancreatic cancer. Now, he's hoping to raise awareness about the deadly disease (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 16, 2017 Category: Consumer Health News Source Type: news

Sabga Foundation pledges $1 million towards TGen pancreatic cancer research
(The Translational Genomics Research Institute) Today, World Pancreatic Cancer Day, is the kickoff of a $1 million drive by the recently formed John E. Sabga Foundation to fund an innovative clinical trial led by the Translational Genomics Research Institute (TGen) to test revolutionary new treatments for pancreatic cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Mother reveals her shocking pancreatic cancer diagnosis
It was in January 2015 that mother and school teacher Natalie Dunne began having back pain after eating or drinking milk products. Little did she know that the cause was pancreatic cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 15, 2017 Category: Consumer Health News Source Type: news

Pancreatic cancer: Is an 'electronic nose' the answer to achieving early diagnosis?
(Spink Health) In research published in the latest edition of the UEG Journal, Scientists demonstrated that there is variance in the volatile compounds found in the urine of pancreatic cancer patients to that of healthy controls. The technique is affordable (each test costs approximately € 20), non-invasive and it is estimated that up to 20 urine samples could be analyzed every hour. The FAIMS test resulted in a sensitivity and specificity of 85 percent and 75 percent respectively. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

ViewRay's net loss narrows in Q3
Image-guided radiation therapy developer ViewRay's net loss narrowed in its...Read more on AuntMinnie.comRelated Reading: ViewRay touts pancreatic cancer study results ViewRay raises $50M in stock sale ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 13, 2017 Category: Radiology Source Type: news

Low-Fat Diet May Cut Pancreatic Cancer Risk
A low-fat diet may lower older women's risk of pancreatic cancer, a new study suggests. (Source: WebMD Health)
Source: WebMD Health - November 10, 2017 Category: Consumer Health News Source Type: news

Low-Fat Diet May Cut Pancreatic Cancer Risk for Overweight Older Women
Title: Low-Fat Diet May Cut Pancreatic Cancer Risk for Overweight Older WomenCategory: Health NewsCreated: 11/9/2017 12:00:00 AMLast Editorial Review: 11/10/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 10, 2017 Category: Cancer & Oncology Source Type: news

Low - Fat Diet May Cut Pancreatic Cancer Risk for Overweight Older Women
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 9, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Geriatrics, Nutrition, News, Source Type: news

Low-Fat Diet May Cut Pancreatic Cancer Risk for Overweight Older Women
Source: HealthDay Related MedlinePlus Pages: Dietary Fats, Pancreatic Cancer, Women's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 9, 2017 Category: Consumer Health News Source Type: news

Low-Fat Diet May Cut Pancreatic Cancer Risk for Overweight Older Women
THURSDAY, Nov. 9, 2017 -- A low-fat diet may lower older women's risk of pancreatic cancer, a new study suggests. The study included more than 46,000 overweight and obese women between the ages of 50 and 79 who ate high-fat diets when they joined a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 9, 2017 Category: General Medicine Source Type: news

USPSTF to review osteoporosis screening
The U.S. Preventive Services Task Force (USPSTF) is seeking comment on a draft...Read more on AuntMinnie.comRelated Reading: USPSTF to take another look at AAA screening USPSTF discourages thyroid cancer screening USPSTF seeks comment on pancreatic cancer guidance USPSTF: Why do more black women die from breast cancer? Ex-USPSTF heads say guidelines shouldn't guide payments (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 9, 2017 Category: Radiology Source Type: news

UCLA helps many to live long and prosper
In Westwood, more than 100 faculty experts from 25 departments have embarked on anall-encompassing push to cut the health and economic impacts of depression in half by the year 2050. The mammoth undertaking will rely on platforms developed by the new Institute for Precision Health, which will harness the power of big data and genomics to move toward individually tailored treatments and health-promotion strategies.On the same 419 acres of land, researchers across the spectrum, from the laboratory bench to the patient bedside, are ushering in a potentially game-changing approach to turning the body ’s immune defenses a...
Source: UCLA Newsroom: Health Sciences - November 9, 2017 Category: Universities & Medical Training Source Type: news

Low-Fat Diet May Cut Pancreatic Cancer Risk for Overweight Older Women
(Source: Cancercompass News: Pancreatic Cancer)
Source: Cancercompass News: Pancreatic Cancer - November 9, 2017 Category: Cancer & Oncology Source Type: news

Back pain warning: Discomfort could actually be a sign of THIS deadly type of cancer
BACK PAIN around the middle of your back could be a symptom of pancreatic cancer, along with abdominal pain and indigestion. (Source: Daily Express - Health)
Source: Daily Express - Health - November 8, 2017 Category: Consumer Health News Source Type: news

Scientists Link Pancreatic Cancer Survival to Four Genes
Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in Jama Oncology. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - November 2, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Scientists link pancreatic cancer survival to four genes
(University of Rochester Medical Center) Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in Jama Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2017 Category: Cancer & Oncology Source Type: news

Africa:Global Coalition Unites to "Demand Better. for Patients. for Survival." On World Pancreatic Cancer Day, Nov. 16
[PR Newswire] Manhattan Beach, California -In honor of World Pancreatic Cancer Day on Nov. 16, people around the world will come together to Demand Better in the fight against the world's toughest cancer, starting with earlier diagnosis. The annual one-day campaign is an initiative of the World Pancreatic Cancer Coalition, which is comprised of more than 60 organizations from 27 countries on six continents. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 1, 2017 Category: African Health Source Type: news

Beware potential signs of pancreatic cancer
One in three adults would dismiss potential symptoms of this all-too-often deadly disease, say experts. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 1, 2017 Category: Consumer Health News Source Type: news

Pancreatic cancer symptoms: One in three would NOT be concerned if they had these signs
ONE in three adults would not be concerned if they were suffering from key symptoms of pancreatic cancer, a charity said. (Source: Daily Express - Health)
Source: Daily Express - Health - November 1, 2017 Category: Consumer Health News Source Type: news

Public urged to know what pancreatic cancer symptoms to look out for
Survey shows public understanding is poor, which may delay prompt diagnosis and treatment Related items fromOnMedica Diabetes can be warning sign for pancreatic cancer Pancreatic cancer is four separate diseases Breakthrough in pancreatic cancer diagnosis Breakthrough in early detection of pancreatic cancer Pancreatic cancer survival has not improved for 40 years (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2017 Category: UK Health Source Type: news

3-D 'scaffold' map to help the search for new cancer treatments
(Walter and Eliza Hall Institute) Researchers have produced the first three-dimensional (3-D) map of a molecular 'scaffold' called SgK223, known to play a critical role in the development and spread of aggressive breast, colon and pancreatic cancers.Armed with the map, the research team is looking at ways of targeting parts of the scaffold molecule critical for its function. They hope the research will lead to novel strategies to target cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2017 Category: Cancer & Oncology Source Type: news

Long-term aspirin use reduces the incidence of digestive cancers by up to 47 percent
(Spink Health) In a study involving over 600,000 people, those prescribed with aspirin showed a 47 percent reduction in liver and esophageal cancer incidence, a 38 percent reduction in gastric cancer incidence, a 34 percent reduction in pancreatic cancer incidence and a 24 percent reduction in colorectal cancer incidence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2017 Category: Cancer & Oncology Source Type: news

Blocking enzyme in normal cells may impede pancreatic cancer, Penn vet team shows
(University of Pennsylvania) New findings from a University of Pennsylvania-led team offer a promising target for future therapies that could potentially root out even the well-hidden metastatic lesions that make pancreatic cancer so deadly. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 27, 2017 Category: Cancer & Oncology Source Type: news

The top 10 medical disruptors of 2018
[Image from unsplash.com]Each year the Cleveland Clinic determines what the top 10 disruptors in healthcare will be for the following year. The criteria to be considered a disruptor or innovation is that it has to be innovative and could change care in a significant way in the next year. Approximately 150 to 200 Cleveland Clinic physicians from each of the institutes are interviewed for their suggestions of the top 10 innovations they think will be a disruptor. Venture capitalists and members of the media also get surveyed to consider the top innovation of the next year. From the large list, 300 to 400 suggestions are...
Source: Mass Device - October 26, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Cardiovascular Diabetes Diagnostics Hospital Care Implants mHealth (Mobile Health) Neuromodulation/Neurostimulation Oncology Patient Monitoring Pharmaceuticals Regenerative Medicine Artificial pancreas Cancer cholesterol Clevel Source Type: news

NovoCure rises on Q3 EPS, sales beat
Shares in Novocure (NSDQ:NVCR) are on the rise today after the medical device maker topped revenue and losses-per-share expectations on Wall Street with its 3rd quarter earnings results. The St. Helier, N.J.-based company posted losses of $11.5 million, or 13¢ per share, on sales of $50.1 million for the 3 months ended September 30, seeing losses on the bottom-line shrink 65.8% while sales grew 131.2% compared with the same period during the previous fiscal year. Losses per share for the quarter came in under the 17¢ consensus on Wall Street, while sales beat the $43.6 million expectations on The Street. &ld...
Source: Mass Device - October 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup NovoCure Source Type: news

SU2C launches 'cancer interception' initiative to detect & treat cancer at earliest stages
(Entertainment Industry Foundation) Stand Up To Cancer (SU2C), the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, have awarded a total of $16.6 million to four teams of top researchers to carry out an attack on cancers of the lung and pancreas using a radical new approach of " interception " of cancers at very early stages when they can be more successfully treated, even catching precancerous cells and blocking them from turning into cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2017 Category: Cancer & Oncology Source Type: news

UC San Diego Health researchers help launch second pancreas cancer 'dream team'
(University of California - San Diego) Scientists and physicians at Moores Cancer Center at UC San Diego Health, in partnership with colleagues at MD Anderson Cancer Center in Texas, Johns Hopkins University in Maryland and elsewhere, have been awarded a $7 million grant over four years by Stand Up to Cancer (SU2C) to create a " dream team " to develop new ways to prevent pancreatic cancer -- one of the nation's deadliest malignancies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 26, 2017 Category: International Medicine & Public Health Source Type: news

ViewRay raises $50M in stock sale
Image-guided radiation therapy developer ViewRay has raised approximately $50...Read more on AuntMinnie.comRelated Reading: ViewRay touts pancreatic cancer study results ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM 1st patients treated with ViewRay's MRIdian system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2017 Category: Radiology Source Type: news

Tumor Size Matters in New TNM Staging of Pancreatic Cancer Tumor Size Matters in New TNM Staging of Pancreatic Cancer
The new eighth edition of the Union for International Cancer Control classification of TNM (tumor-node-metastasis) staging for pancreatic cancer includes more T and N stages that better predict overall survival.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 25, 2017 Category: Pathology Tags: Hematology-Oncology News Source Type: news

ViewRay touts pancreatic cancer study results
Image-guided radiation therapy developer ViewRay is touting study results showing...Read more on AuntMinnie.comRelated Reading: ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM 1st patients treated with ViewRay's MRIdian system ViewRay sees drop in Q1 revenue (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2017 Category: Radiology Source Type: news

Pancreatic Cancer in Children
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 25, 2017 Category: General Medicine Source Type: news

Anti-pancreatic cancer drug in research focus
(Wiley) Intriguing antitumor activity is found in a very promising class of natural compounds: cyclic depsipeptides, which have a challenging structure that makes their investigation difficult. Now, Chinese scientists have established the synthesis of a member compound, which is especially promising in killing pancreatic cancer stem cells. They describe its total synthesis and first test results in the journal Angewandte Chemie; the results point to an unprecedented activity towards one of the deadliest cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 25, 2017 Category: Cancer & Oncology Source Type: news

A supersuppressor for pancreatic cancer
A mutation in p53 enhances its induction of a phosphatase that inhibits YAP, a critical mediator of pancreatic cancer development. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - October 24, 2017 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

RedHill lands new orphan drug designation, looks to grow commercial portfolio
At a time when RedHill Biopharma (NASDAQ: RDHL) is looking to grow its commercial portfolio, the company has landed U.S. Food and Drug Administration Orphan Drug Designation for MESUPRON for the treatment of pancreatic cancer – a market for which sales are expected to be $1.6 billion this year.  Benefits of the designation include development incentives and tax credits, as well as potentially a prescription drug user fee waiver and seven-year exclusive marketing period, if MESUPRON is ultimately… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 23, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

RedHill lands new orphan drug designation, looks to grow commercial portfolio
At a time when RedHill Biopharma (NASDAQ: RDHL) is looking to grow its commercial portfolio, the company has landed U.S. Food and Drug Administration Orphan Drug Designation for MESUPRON for the treatment of pancreatic cancer – a market for which sales are expected to be $1.6 billion this year.  Benefits of the designation include development incentives and tax credits, as well as potentially a prescription drug user fee waiver and seven-year exclusive marketing period, if MESUPRON is ultimately… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 23, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Rockville-based cancer therapy company CytImmune Sciences in fundraising mode
The company is working on a therapy for pancreatic cancer using nanotechnology. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 23, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

Rockville-based cancer therapy company CytImmune Sciences in fundraising mode
The company is working on a therapy for pancreatic cancer using nanotechnology. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 23, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news

Rockville-based cancer therapy company Cytimmune Sciences in fundraising mode
The company is working on a therapy for pancreatic cancer using nanotechnology. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 20, 2017 Category: Health Management Authors: Tina Reed Source Type: news

Study reveals key molecular link in major cell growth pathway
(Whitehead Institute for Biomedical Research) A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. The researchers' findings also implicate a new protein, SLC38A9, as a potential drug target in pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2017 Category: Cancer & Oncology Source Type: news

Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer
(ViewRay) A retrospective review of 42 inoperable, locally-advanced pancreatic cancer patients treated at four institutions found that higher delivered radiation doses enabled via ViewRay's MRIdian adaptive MR-guided radiation therapy showed a near doubling of median overall survival (27.8 months compared to 14.8 months) and resulted in favorably lower toxicities (0 percent compared to 15.8 percent grade 3 or higher toxicity). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2017 Category: Cancer & Oncology Source Type: news

In Memory of Mike Guttenberg
  Photo Courtesy Craig Smith/Northwell Health   It is with great sadness that I share news of the loss of Dr. Michael Guttenberg, Northwell Health's medical director of clinical preparedness and our Center for Emergency Medical Services (CEMS), who died this morning after a lengthy battle with cancer. Mike spent more than 30 years delivering emergency medical services in the City of New York as an EMT, paramedic field provider and physician.  He first joined Northwell Health as chair of emergency medicine at LIJ Forest Hills, and had served as medical director of CEMS since 2016. While with the Fire Departm...
Source: JEMS Administration and Leadership - October 17, 2017 Category: Emergency Medicine Authors: Michael Dowling Tags: Administration and Leadership Source Type: news

TGen receives $2.5 million SU2C grant for new pancreatic cancer clinical trial
(The Translational Genomics Research Institute) Stand Up To Cancer (SU2C) has awarded a $2.5 million SU2C CatalystR grant to the Translational Genomics Research Institute (TGen) to investigate a revolutionary new method of treating pancreatic cancer, one of the most aggressive of all cancers. Dr. Daniel Von Hoff, TGen Distinguished Professor and Physician-In-Chief, will lead a pancreatic cancer clinical trial that will pair an immunotherapy drug called pembrolizumab (trademarked as Keytruda ® ), with a Vitamin D Receptor (VDR) agonist called paricalcitol (trademarked as Zemplar ® ). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 13, 2017 Category: Cancer & Oncology Source Type: news

Pancreatic Cancer Patients'Going the Extra Mile' for Survival Pancreatic Cancer Patients'Going the Extra Mile' for Survival
Dr Lowenfels comments on a study comparing survival rates of patients who underwent Whipple procedures at local facilities vs those traveling a longer distance and treated at high-volume centers.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 12, 2017 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news

Salk researchers awarded $2.5 million for innovative pancreatic cancer clinical trial
(Salk Institute) Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up 2 Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 12, 2017 Category: Cancer & Oncology Source Type: news

Medical News Today: 'Super tumor suppressor' found to prevent pancreatic cancer
Researchers have found a mutation in the p53 gene that boosts its tumor-suppressing abilities. The mutation halted pancreatic cancer in mice. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 10, 2017 Category: Consumer Health News Tags: Pancreatic Cancer Source Type: news

Pancreatic cancer patients ‘could LIVE LONGER with antibiotics’
PANCREATIC cancer patients could get “more hope and more life” after scientists found antibiotics could make chemotherapy treatment more effective. (Source: Daily Express - Health)
Source: Daily Express - Health - October 6, 2017 Category: Consumer Health News Source Type: news

DSI professor conducts research to combat pancreatic cancer
(Data Science Institute at Columbia) Tal Danino, a professor at the Data Science Institute, is conducting research that could help scientists combat the most lethal of cancers: pancreatic cancer.In a recent study, working with a team of researchers, Danino demonstrated that bacteria in pancreatic tumors degrade a chemotherapy drug -- Gemcitabine -- most commonly used to treat patients who have pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 5, 2017 Category: Cancer & Oncology Source Type: news